9:36 AM ET
Form 4
Insider Buying
Actuate Therapeutics President, CEO and Director Daniel M. Schmitt Buys $50K of Stock
Daniel M. Schmitt, President, CEO and Director, bought 140,844 shares of Actuate Therapeutics, Inc. at $0.355 a share, worth $50K in total on Oct 28, 2026. Shares held after the trade: 442,560 (+46.7%).
- Value
- $50K
- Shares
- 140,844
- Price
- $0.3550
- Role
- President, CEO and Director
- Holding change
- +46.7%
- Trade date
- Oct 28, 2026